Literature DB >> 7306930

A comparison of cancer risk in Crohn's disease and ulcerative colitis.

A J Greenstein, D B Sachar, H Smith, H D Janowitz, A H Aufses.   

Abstract

The authors estimated cancer risk among 589 patients hospitalized with Crohn's disease between 1960-1976 by calculating the ratios of observed number of cancers (O) in our hospital sample to the expected number of cancers (E) based on the age- and sex-specific cancer rates of a standard population. The authors then compared these O/E ratios with the O/E ratios similarly calculated among 267 patients hospitalized with ulcerative colitis. The risk of colorectal cancer was significantly increased in Crohn's disease (O/E = 6.9, P less than 0.001). This increase was similar in magnitude to that found in left-sided ulcerative colitis (O/E = 8.6, P less than 0.001) but was much less than that found in universal ulcerative colitis (O/E = 26.5, P less than 0.001). The incidence of small bowel cancer was greatly increased in the combined group of regional enteritis and ileocolitis (O/E = 85.8, P less than 0.001), and even more so in the regional enteritis group alone (O/E = 114.5, P less than 0.001). The incidence of extraintestinal cancer did not increase in any of the patient groups.

Entities:  

Mesh:

Year:  1981        PMID: 7306930     DOI: 10.1002/1097-0142(19811215)48:12<2742::aid-cncr2820481231>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  51 in total

Review 1.  Inflammatory bowel disease and cancer.

Authors:  B Cola
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

2.  The malignant potential of colorectal Crohn's disease.

Authors:  M G Wyatt; P W Houghton; N J Mortensen; R C Williamson
Journal:  Ann R Coll Surg Engl       Date:  1987-09       Impact factor: 1.891

3.  DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study.

Authors:  R Porschen; U Robin; A Schumacher; S Schauseil; F Borchard; K J Hengels; G Strohmeyer
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

4.  Rectal mucosal dysplasia in Crohn's disease.

Authors:  B I Korelitz; G Y Lauwers; S C Sommers
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

Review 5.  Inflammatory bowel disease: the problems of dysplasia and surveillance.

Authors:  P J Mitchell; E Salmo; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2007-11-30       Impact factor: 3.781

6.  Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease.

Authors:  Alicia Algaba; Iván Guerra; Angel Castaño; Gema de la Poza; Víctor M Castellano; Montserrat López; Fernando Bermejo
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 7.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

8.  Crohn's disease of the duodenum complicated by adenocarcinoma.

Authors:  M S Meiselman; G G Ghahremani; M W Kaufman
Journal:  Gastrointest Radiol       Date:  1987

9.  Bowel cancer characteristics in patients with regional enteritis.

Authors:  T L Miller; J Skucas; D Gudex; C Listinsky
Journal:  Gastrointest Radiol       Date:  1987

10.  Crohn's disease and colorectal cancer.

Authors:  C D Gillen; H A Andrews; P Prior; R N Allan
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.